COVID-19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: In this group of patients with COVID-19, in addition to standard treatment introduced by the Ministry of Health, the second drug is also prescribed. It is a licoric
Sponsors
Artesh University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Admitted patients with COVID-19 in the four hospitals of AJA medical University in Tehran COVID-19 diagnosed by lung CT or naso-pharyngeal PCR
Exclusion criteria
Exclusion criteria: Severe hypersensitivity to the Licorice DKA or NKHC Pregnancy Decompensated Cirrhosis Non viral sepsis Active GIB Acute trauma or Surgical problem Unstable angina or Acute MI Chronic renal failure with Uremic symptoms
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Admission time. Timepoint: Daily. Method of measurement: Patients' profile (Yes or no). | — |
Secondary
| Measure | Time frame |
|---|---|
| C-reactive protein. Timepoint: On admission, On discharge. Method of measurement: Laboratory test.;Differences in lymphocyte count. Timepoint: on admission, on discharge. Method of measurement: with the cell counter device.;The death number. Timepoint: at the end of admission. Method of measurement: base on the patient registries. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Saeed Soleiman Meigooni
Artesh University of Medical Sciences
Outcome results
None listed